# US 2022/0024994 A9 · Transmembrane pore consisting of two csgg pores

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0024994 A9
- Document ID: US20220024994A9
- Status: Published application
- Kind: A9
- Application number: 16/610,895
- Filed: 2018-05-03
- Published: 2022-01-27
- Earliest claimed: 2017-05-04
- Assignees: Oxford Nanopore Technologies PLC; Vib Vzw; Vrije Universiteit Brussel
- Applicants: Oxford Nanopore Technologies Limited; Vib Vzx; Vrije Universiteit Brussel
- Inventors: Lakmal Nishantha Jayasinghe; Elizabeth Jayne Wallace; Pratik Raj Singh; Richard George Hambley; Michael Jordan; Han Remaut
- Web page: https://patentgrep.com/patent/US20220024994A9

## CPC

- C07K 14/245: Escherichia (G)
- C12Q 1/6869: Methods for sequencing
- G01N 27/44791: {Microapparatus (sample containers with integrated microfluidic structures B01L3/5027)}
- G01N 33/48721: {Investigating individual macromolecules, e.g. by translocation through nanopores (Coulter counters in general G01N15/12; fabrication methods for nanoscale apertures B81B1/00; sequencing of nucleic acids C12Q1/68)}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Provided is a method of characterising a polynucleotide using a transmembrane pore, wherein the pore is a double pore comprising a first Csg G pore, or a homologue thereof, and a second CsgG pore, or a homologue thereof.

## Claims

### Claim 1

A method of characterising a polynucleotide using a transmembrane pore,
wherein the pore is a double pore comprising a first CsgG pore, or a homologue thereof, and a second CsgG pore, or a homologue thereof.

### Claim 2 (depends on 1)

A method according to claim 1, wherein the polynucleotide comprises a homopolymeric region.

### Claim 3

(canceled)

### Claim 4 (depends on 1)

A method according to claim 1, wherein the first CsgG pore, or homologue thereof, is a homooligomer and the second CsgG pore, or homologue thereof, is a homooligomer.

### Claim 5

(canceled)

### Claim 6

A double pore comprising a first CsgG pore, or a homologue thereof, and a second CsgG pore, or a homologue thereof, wherein:
(i) the first CsgG pore, or homologue thereof, is a homooligomer and the second CsgG pore, or homologue thereof, is a homooligomer, and the first CsgG pore, or homologue thereof, comprises monomers that have a different amino acid sequence from the monomers of which the second CsgG pore, or homologue thereof, is comprised;
(ii) the first CsgG pore, or homologue thereof, is a homooligomer and the second CsgG pore, or homologue thereof, is a homooligomer, and the first CsgG pore, or homologue thereof, and/or the second CsgG pore, or homologue thereof is not a wild-type pore, optionally wherein the first CsgG pore or homologue thereof, and the second CsgG pore, or homologue thereof are identical;
(iii) the first CsgG pore, or homologue thereof, is a heterooligomer and the second CsgG pore, or homologue thereof, is a homooligomer;
(iv) the first CsgG pore, or homologue thereof, is a homooligomer and the second CsgG pore, or homologue thereof, is a heterooligomer;
(v) the first CsgG pore, or homologue thereof, is a heterooligomer and the second CsgG pore, or homologue thereof, is a heterooligomer, optionally wherein the first CsgG pore, or homologue thereof, and the second CsgG pore, or homologue thereof are identical.

### Claim 7

(canceled)

### Claim 8 (depends on 6)

A double pore according to claim 6, wherein the first CsgG pore, or homologue thereof, and the second CsgG pore, or homologue thereof, are different.

### Claim 9 (depends on 6)

A double pore according to claim 6, wherein the first CsgG pore, or homologue thereof, and the second CsgG pore, or homologue thereof, are in opposite orientations.

### Claim at position 10

10-11. (canceled)

### Claim 12 (depends on 6)

A double pore according to claim 6, wherein the first CsgG pore, or homologue thereof, is attached to the second CsgG pore, or homologue thereof, by hydrophobic interactions and/or by one or more disulphide bond and wherein at least one monomer in the first CsgG pore, or homologue thereof, and/or at least one monomer in the second CsgG pore, or homologue thereof, comprises at least one cysteine residue at the interface between the first and second pores, which cysteine residue is not present in the wild type CsgG monomer, or the wild type CsgG homologue monomer, optionally wherein the cysteine residue at the interface between the first and second pores is at a position corresponding to R97, I107, R110, Q100, E101, N102 and/or L113 of SEQ ID NO:2.

### Claim 13

(canceled)

### Claim 14 (depends on 6)

A double pore according to claim 6, wherein the first CsgG pore, or homologue thereof, is attached to the second CsgG pore, or homologue thereof, by hydrophobic interactions and/or by one or more disulphide bond and wherein at least one monomer in the first CsgG pore, or homologue thereof, and/or at least one monomer in the second CsgG pore, or homologue thereof, comprises at least one residue at the interface between the first and second pores, which residue is more hydrophobic than the residue present at the corresponding position in the wild type CsgG monomer, or the wild type CsgG homologue monomer, optionally wherein the at least one residue at the interface between the first and second pores is at a position corresponding to R97, I107, R110, Q100, E101, N102 and or L113 of SEQ ID NO:2, and optionally wherein the at least one residue at the interface between the first and second pores is:
(i) I, L, V, M, F, W, Y, where the residue present at the corresponding position in the wild type CsgG monomer, or the wild type CsgG homologue monomer is R, Q, N or E;
(ii) L, V, M, F, W, Y, where the residue present at the corresponding position in the wild type CsgG monomer, or the wild type CsgG homologue monomer is I; and/or
(iii) C, I, V, M, F, W, Y, where the residue present at the corresponding position in the wild type CsgG monomer, or the wild type CsgG homologue monomer is L.

### Claim at position 14

15-16. (canceled)

### Claim 17 (depends on 6)

A double pore according to claim 6, wherein at least one monomer in the first CsgG pore, or homologue thereof, and/or at least one monomer in the second CsgG pore, or homologue thereof, comprises at least one residue at the interface between the first and second pores, which residue is bulkier than the residue present at the corresponding position in the wild type CsgG monomer, or the wild type CsgG homologue monomer, wherein the at least one residue at the interface between the first and second pores is at a position corresponding to A98, A99, T104, V105, L113, Q114 or S115 of SEQ ID NO: 2, and optionally wherein the at least one residue at the interface between the first and second pores is:
(i) I, L, V, M, F, W, Y, N, Q, S or T where the residue present at the corresponding position in the wild type CsgG monomer, or the wild type CsgG homologue monomer is A;
(ii) L, M, F, W, Y, N, Q, R, D or E where the residue present at the corresponding position in the wild type CsgG monomer, or the wild type CsgG homologue monomer is T;
(iii) I, L, M, F, W, Y, N, Q where the residue present at the corresponding position in the wild type CsgG monomer, or the wild type CsgG homologue monomer is V;
(iv) M, F, W, Y, N, Q, R, D or E where the residue present at the corresponding position in the wild type CsgG monomer, or the wild type CsgG homologue monomer is L;
(v) F, W, Y where the residue present at the corresponding position in the wild type CsgG monomer, or the wild type CsgG homologue monomer is Q; and/or
(vi) M, F, W, Y, N, Q, E or R where the residue present at the corresponding position in the wild type CsgG monomer, or the wild type CsgG homologue monomer is S.

### Claim at position 16

18-19. (canceled)

### Claim 20 (depends on 6)

A double pore according to claim 6, wherein at least one monomer in the first CsgG pore, or homologue thereof, and/or at least one monomer in the second CsgG pore, or homologue thereof, comprises at least one residue in the barrel region of the pore, which residue has less negative charge than the residue present at the corresponding position in the wild type CsgG monomer, or the wild type CsgG homologue monomer, optionally wherein the at least one residue in the barrel region of the pore is at a position corresponding to D149, E185, D195, E210 and/or E203 of SEQ ID NO: 2.

### Claim at position 18

-22. (canceled)

### Claim 23 (depends on 6)

A double pore according to claim 6, wherein at least one monomer in the first CsgG pore, or homologue thereof, comprises at least one residue in the constriction of the barrel region of the first pore, which residue decreases, maintains or increases the length of the constriction compared to the wild type CsgG pore, or the wild type CsgG homologue pore, and/or at least one monomer in the second CsgG pore, or homologue thereof, comprises at least one residue in the constriction of the barrel region of the second pore, which residue decreases, maintains or increases the length of the constriction compared to the wild type CsgG pore, or the wild type CsgG homologue pore, optionally wherein the at least one residue is between the residues corresponding to K49 and P50, P50 and Y51, Y51 and P52, P52 and A53, A53 and S54, S54 and N55 and/or N55 and F56 of SEQ ID NO:2, or wherein the at least one residue increases the length of the loop between the residues corresponding to Y51 and N55 of SEQ ID NO:2 or, wherein the at least one residue is:
(i) A, S, G or T;
(ii) P; and/or
(iii) S, T, N, Q, M, F, W, Y, V and/or I.

### Claim at position 20

24-27. (canceled)

### Claim 28 (depends on 6)

A double pore according to claim 6, wherein at least one monomer in the first CsgG pore, or homologue thereof, comprises at least one residue in the construction of the barrel region of the first pore, which residue decreases, maintains or increases the length of the constriction compared to the wild type CsgG pore, or the wild type CsgG homologue pore, and/or at least one monomer in the second CsgG pore, or homologue thereof, comprise at least one residue in the constriction of the barrel region of the second pore, which residue decreases, maintains or increases the length of the constriction compared to the wild type CsgG pore, or the wild type CsgG homologue pore, wherein the at least one residue is S, G, SG, SGG, SGS, GS, GSS and/or GSG or wherein the at least one residue in the constriction of the barrel region of the pore is at a position corresponding to Y51, N55, Y51, P52 and/or A53 of SEQ ID NO:2, optionally wherein the at least one residue is:
(i) Q or V at a position corresponding to F56 of SEQ ID NO:2;
(ii) A or Q at a position corresponding to Y51 of SEQ ID NO:2; and/or
(iii) V at a position corresponding to N55 of SEQ ID NO:2.

### Claim at position 22

29-32. (canceled)

### Claim 33

A CsgG monomer, or a monomer of a CsgG homologue, comprising:
(i) a cysteine residue at a position corresponding to R97, I107, R110, Q100, E101, N102 and or L113 of SEQ ID NO: 2;
(ii) a residue at a position corresponding to any one or more of R97, Q100, I107, R110, E101, N102 and L113 of SEQ ID NO: 2, which residue is more hydrophobic than the residue present at the corresponding position of SEQ ID NO: 2, or in the amino acid sequence of a wild type CsgG homologue, wherein the residue at the position corresponding to R97 and/or I107 is M, the residue at the position corresponding to R110 is I, L, V, M, W or Y, and/or the residue at the position corresponding to E101 or N102 is V or M;
(iii) a residue at a position corresponding to any one or more of A98, A99, T104, V105, L113, Q114 and S115 of SEQ ID NO: 2 which is bulkier than the residue present at the corresponding position of SEQ ID NO: 2, or in the amino acid sequence of a wild type CsgG homologue, wherein the residue at the position corresponding to T104 is L, M, F, W, Y, N, Q, D or E, the residue at the position corresponding to L113 is M, F, W, Y, N, G, D or E and/or the residue at the position corresponding to S115 is M, F, W, Y, N, Q or E; and/or
(iv) a residue in the barrel region of the pore at a position corresponding to any one or more of D149, E185, D195, E210 and E203 which has less negative charge than the residue present at the corresponding position in the wild type CsgG monomer, or the wild type CsgG homologue monomer, wherein the residue at the position corresponding to D149, E185, D195 and/or E203 is K.

### Claim 34 (depends on 33)

A monomer according to claim 33, wherein:
(i) the residue at a position corresponding to Q100 is I, L, V, M, F, W or Y;
(ii) the residue at a position corresponding to L113 is I, V, M, F, W or Y;
(iii) the residue at a position corresponding to A98 or A99, is I, L, V, M, F, W, Y, N, Q, S or T;
(iv) the residue at a position corresponding to V105 is I, L, M, F, W, Y, N or Q;
(v) the residue at a position corresponding to Q114 is F, W or Y; and/or
(vi) the residue at a position corresponding to E210 is N, Q, R or K.

### Claim 35

A CsgG monomer, or a monomer of a CsgG homologue, wherein at least one monomer in the first CsgG pore, or homologue thereof, and/or at least one monomer in the second CsgG pore, or homologue thereof, comprises at least one residue in the constriction of the barrel region of the pore, which residue increases the length of the constriction compared to the wild type CsgG pore, or the wild type CsgG homologue pore, optionally wherein the at least one residue is additional to the residues present in the constriction of the wild type CsgG pore, or the wild type CsgG homologue pore.

### Claim 36

(canceled)

### Claim 37 (depends on 35)

A monomer according to claim 35, wherein the at least one residue is between the residues corresponding to K49 and P50, P50 and Y51, Y51 and P52, P52 and A53, A53 and S54, S54 and N55 and/or N55 and F56 of SEQ ID NO: 2, or wherein residue increases the length of the loop between the residues corresponding to Y51 and N55 of SEQ ID NO: 2, optionally wherein the at least one residue is:
(i) A, S, G or T;
(ii) P; and/or
(iii) S, T, N, Q, M, F, W, Y, V and/or I.

### Claim at position 28

-39. (canceled)

### Claim 40 (depends on 35)

A CsgG monomer, a monomer of a CsgG homologue according to claim 35, wherein the at least one residue is S, G, SG, SGG, SGS, GS, GSS and/or GSG.

### Claim 41 (depends on 35)

A CsgG monomer, or a monomer of a CsgG homologure according to claim 35, wherein the at least one residue in the constriction of the barrel region of the pore is at a position corresponding to N55, P52 and/or A53 of SEQ ID NO: 2, wherein the residue at a position corresponding to N55 is V.

### Claim at position 31

42-46. (canceled)

### Claim 47 (depends on 6)

A method for determining the presence, absence or one or more characteristics of a target analyte, comprising:
(a) contacting the target analyte with a double pore according to claim 6 such that the target analyte moves with respect to the pore; and
(b) taking one or more measurements as the analyte moves with respect to the pore and thereby determining the presence, absence or one or more characteristics of the analyte.

### Claim at position 33

48-52. (canceled)

### Claim 53 (depends on 6)

An apparatus for characterising target analytes in a sample, comprising an array of double pores according to claim 6 in a plurality of membranes.

### Claim at position 35

54-56. (canceled)
